record state
frontier-ownedReview status
This finding is part of accepted frontier state. Review events, reviewable changes, and proof state explain how it can change.
unreviewed
frontiers / frontier
Finding bundle
back to stateno incoming links yet
record state
frontier-ownedThis finding is part of accepted frontier state. Review events, reviewable changes, and proof state explain how it can change.
finding statement
finding typeNo entity list is declared.
evidence
source-boundtheoretical · manual state transition
proof impact
packet context1 reviewable changes and 0 evaluation records are attached to this finding id.
Evidence and conditions
method
manual state transition
evidence type
theoretical
conditions
Provenance
source title
A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered (Acta Neuropathologica)
authors
reviewer:will-blair
A subgroup of H3K27M-mutant DMGs with concurrent MAPK pathway alterations (BRAF/FGFR1 mutations) or EGFR/ACVR1 mutations define distinct molecular subtypes with differential survival and drug responsiveness, suggesting genomic context-dependent therapeutic strategies
vs_2e6ba54261b26552 · manual_curation
outgoing
No outgoing links.
incoming
No incoming links.
events
vev_ababf589d217813ffinding.assertedManual finding added to frontier state
reviewer:will-blair · 2026-05-29
reviewable changes
vpr_6904efc681b90906finding.addManual finding added to frontier state
applied · reviewer:will-blair · 2026-05-29
evaluations
No evaluation record targets this finding id.